Categories: Stock Market

First Week of April 21st Options Trading For BioCryst Pharmaceuticals (BCRX)

Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BCRX options chain for the new April 21st contracts and identified the following put contract of particular interest.

The put contract at the $8.00 strike price has a current bid of 10 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $8.00, but will also collect the premium, putting the cost basis of the shares at $7.90 (before broker commissions). To an investor already interested in purchasing shares of BCRX, that could represent an attractive alternative to paying $8.26/share today.

Because the $8.00 strike represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 66%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.25% return on the cash commitment, or 65.18% annualized — at Stock Options Channel we call this the YieldBoost.

Below is a chart showing the trailing twelve month trading history for BioCryst Pharmaceuticals Inc, and highlighting in green where the $8.00 strike is located relative to that history:


The implied volatility in the put contract example above is 69%.

Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 250 trading day closing values as well as today’s price of $8.26) to be 60%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.

Top YieldBoost Puts of the S&P 500 »

Also see:

• Utilities Dividend Stock List
• CHAD shares outstanding history
• Top Ten Hedge Funds Holding GCV

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source link

nasdaqpicks.com

Share
Published by
nasdaqpicks.com

Recent Posts

Sebi proposes to allow investment advisers, research analysts to charge advance fee for up to 1 year

The Securities and Exchange Board of India (Sebi) on Wednesday floated a consultation paper, proposing…

11 seconds ago

SEBI’s new proposal eases compliance burden on Research Analysts

In a major relief to research analysts, the Securities and Exchange Board of India (SEBI)…

7 minutes ago

Upcoming IPO: BD Securities gets NSE approval to raise funds via public issue

Upcoming IPO: BD Security Limited (BDS), a security services provider and Telecom O&M has received…

11 minutes ago

Tory MP’s killer released from UK anti-terror scheme too early, review finds

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

12 minutes ago

Kaveri Seeds Q3 PAT up 29%

Kaveri Seed Company Limited has posted a net profit of ₹15 crore in the third…

14 minutes ago

Volatility hits retail investors: NSE sees drop in active clients, demat accounts in January

In a battered market retail investor confidence is faltering as heightened volatility slows active client…

21 minutes ago